BriaCell Therapeutics Corp. (BCT)

BriaCell Therapeutics Corp. (BCT $2.77)
- $2.77 Cap: $10M
- View BCT Profile
- View Questions on BCT

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Telo Genomics Corp. (TELO)
- Fwd P/E: -21.9X Cap: $2M
- View TELO Profile
- View Questions on TELO
Medicenna Therapeutics Corp. (MDNA $0.83)
- $0.83 Cap: $68M
- View MDNA Profile
- View Questions on MDNA
BioMarin Pharmaceutical Inc. (BMRN $58.23)
- $58.23 Fwd P/E: 21.6X Cap: $11.44B
- View BMRN Profile
- View Questions on BMRN
CRISPR Therapeutics AG (CRSP $56.42)
- $56.42 Cap: $4.90B
- View CRSP Profile
- View Questions on CRSP
BriaCell Therapeutics Corp. (BCT $2.77)
- $2.77 Cap: $10M
- View BCT Profile
- View Questions on BCT
Guardant Health Inc. (GH $49.77)
- $49.77 Cap: $6.22B
- View GH Profile
- View Questions on GH
Twist Bioscience Corporation (TWST $37.80)
- $37.80 Cap: $2.27B
- View TWST Profile
- View Questions on TWST
NurExone Biologic Inc. (NRX $0.75)
- $0.75 Cap: $58M
- View NRX Profile
- View Questions on NRX
Tempus AI Inc. (TEM $57.82)
- $57.82 Cap: $10B
- View TEM Profile
- View Questions on TEM

Q: The best Canadian public genomic stocks to buy now?

The best public genomic stocks in the world to buy now?

Thank you.

Read Answer Asked by Ross on July 10, 2025

BriaCell Therapeutics Corp. (BCT $2.77)
- $2.77 Cap: $10M
- View BCT Profile
- View Questions on BCT

Q: I know it's tricky to evaluate a potential pharma cancer treatment equity but what do you think about this one? It looks like they'll need to dilute massively soon which likely explains my current ~80% paper loss. It's in my TFSA (stupid move on my part as it turns out). Time to take my hit and move on or hope for a miracle?

Read Answer Asked by DAVE on April 01, 2024

BriaCell Therapeutics Corp. (BCT $2.77)
- $2.77 Cap: $10M
- View BCT Profile
- View Questions on BCT

Q: Good Day.
Wondering if you could, "feed me a fish," by finding the short positions in both the US and CAN markets; then "teach me to fish" by showing me where I can source this data on my own. I cannot remember where I have found it in the past.
Thanks

Read Answer Asked by Robert on November 07, 2023